MedLink , a leading provider of Electronic Health Records and practice management solutions, is pleased to announce the acquisition of LabTestPortal, a direct-to-consumer laboratory testing platform. The acquisition provides MedLink with an entry into the direct-to-consumer laboratory testing market which has gained significant traction in the more than $50 billion U.S. laboratory testing market.
LabTestPortal is a service provider that delivers direct-to-consumer secure and confidential laboratory testing to consumers, that eliminates the need to see a primary care physician and receive insurance approval for maintenance and advanced lab tests. Through a Personal Health Record portal, consumers are able to track their lab testing results as well as store vital healthcare documents and information and receive results in most cases in less than 48 hours.
Ray Vuono, President of MedLink, stated, “The market for DTC lab testing has experienced an annual growth rate of 15-20 %, due to Consumers continuing to take charge of their own health through disease prevention and early detection. With managed care companies, as well as Medicare and Medicaid refusing to pay in most cases for tests without ‘symptoms of disease,’ DTC laboratory testing presents the only avenue for disease prevention for most consumers.” Mr. Vuono continued, “MedLink’s entry into the DTC lab test market, establishes a differentiator for MedLink in the EHR and Healthcare IT marketplace, providing services and synergies that enhance MedLink’s overall offering not only to the end user patient but as an added benefit to the MedLink Lab outreach program and RHIO Financial Sustainability model.”